Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseaseStem CellsPeripheral Blood Stem Cell TransplantationHematologic NeoplasmsBone Marrow TransplantationTransplantation ChimeraTissue DonorsTreatment OutcomeCord Blood Stem Cell TransplantationHematopoiesisGraft SurvivalHistocompatibility TestingMyeloablative AgonistsWhole-Body IrradiationHematopoietic Stem Cell MobilizationBusulfanHistocompatibilityAntigens, CD34ChimerismGraft vs Leukemia EffectLeukemiaRetrospective StudiesLiver TransplantationRecurrenceCell DifferentiationBone Marrow CellsMesenchymal Stem Cell TransplantationImmunosuppressive AgentsHematologic DiseasesRemission InductionCombined Modality TherapyHepatic Veno-Occlusive DiseaseHLA AntigensMultiple MyelomaCell LineageSiblingsCell TransplantationUnrelated DonorsVidarabineTime FactorsLeukemia, Myeloid, AcuteMyelodysplastic SyndromesStem Cell NicheMice, Inbred C57BLFlow CytometrySurvival RateEmbryonic Stem CellsGraft vs Tumor EffectTransplantation ImmunologyAdult Stem CellsDisease-Free SurvivalSurvival AnalysisSevere Combined ImmunodeficiencyMelphalanKidney TransplantationLymphocyte TransfusionBone MarrowFetal BloodTransplantation, IsogeneicCyclophosphamideColony-Forming Units AssayT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaGranulocyte Colony-Stimulating FactorSalvage TherapyCytomegalovirus InfectionsAntilymphocyte SerumCells, CulturedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticDonor SelectionLymphocyte DepletionFollow-Up StudiesAllograftsAcute DiseaseGraft RejectionAntineoplastic Combined Chemotherapy ProtocolsCell SeparationMesenchymal Stromal CellsImmunosuppressionCell ProliferationPluripotent Stem CellsMultipotent Stem CellsOpportunistic InfectionsImmunocompromised HostStem Cell FactorLymphoma, Non-HodgkinLymphoproliferative DisordersOrgan TransplantationImmune SystemTransplantationHeart TransplantationMice, SCIDPrognosis